Drug Profile
LU AA 47070
Alternative Names: Lu AA47070Latest Information Update: 18 May 2009
Price :
$50
*
At a glance
- Originator Lundbeck A/S
- Class
- Mechanism of Action Purinergic P1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 13 Nov 2007 Phase-I clinical trials in Parkinson's disease in Denmark (unspecified route)